Market News
Global Multiomics Market- Recent Developments
Business Development Activities by the Market Players
- On September 12, 2023, the National Institutes of Health announced that it is establishing the Multi-Omics for Health and Disease Consortium, with approximately US$11 million awarded in the consortium’s first year of funding. The new consortium aims to advance the generation and analysis of “multi-omic” data for human health research.
- In September 2023, MGI, a company specializing in life science technology and tools, launched the DCS Lab Initiative. This initiative aims to boost important scientific research and promote the development of large-scale multiomics labs. As part of this initiative, MGI is providing products for a variety of applications such as cell omics, DNA sequencing, and spatial omics, which are based on DNBSEQ technologies. These products are being offered to selected research institutions worldwide.
- On May 4, 2023, MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, closed a (£5 million) US$6.2 million seed funding extension round to build its precision therapeutics discovery platform for metabolic syndrome-related medical conditions. The round was led by London-based Hoxton Ventures, with participation from Ada Ventures, MMC Ventures, and Verve Ventures.
- On February 3, 2023, BD (Becton, Dickinson and Company), a leading global medical technology company, announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing sample integrity – potentially accelerating time to discovery across a wide range of disciplines including immunology, genetic disease research, and cancer and chronic disease research.
U.S.: 
U.K. : 
India : 
